These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25154741)
21. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression. Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029 [TBL] [Abstract][Full Text] [Related]
22. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. Goto Y; Nishikawa R; Kojima S; Chiyomaru T; Enokida H; Inoguchi S; Kinoshita T; Fuse M; Sakamoto S; Nakagawa M; Naya Y; Ichikawa T; Seki N FEBS Lett; 2014 May; 588(10):1973-82. PubMed ID: 24768995 [TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431 [TBL] [Abstract][Full Text] [Related]
24. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059 [TBL] [Abstract][Full Text] [Related]
25. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII. Zhang W; Liu J; Qiu J; Fu X; Tang Q; Yang F; Zhao Z; Wang H Oncol Rep; 2016 Dec; 36(6):3707-3715. PubMed ID: 27748848 [TBL] [Abstract][Full Text] [Related]
28. miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma. Shui Y; Yu X; Duan R; Bao Q; Wu J; Yuan H; Ma C Gene; 2017 Apr; 609():80-87. PubMed ID: 28163094 [TBL] [Abstract][Full Text] [Related]
29. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. Ramalho-Carvalho J; Graça I; Gomez A; Oliveira J; Henrique R; Esteller M; Jerónimo C J Hematol Oncol; 2017 Feb; 10(1):43. PubMed ID: 28166834 [TBL] [Abstract][Full Text] [Related]
31. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells. Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210 [TBL] [Abstract][Full Text] [Related]
32. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542 [TBL] [Abstract][Full Text] [Related]
33. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines. Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133 [TBL] [Abstract][Full Text] [Related]
34. miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2). Wang H; Zhu Y; Zhao M; Wu C; Zhang P; Tang L; Zhang H; Chen X; Yang Y; Liu G PLoS One; 2013; 8(8):e70192. PubMed ID: 23936390 [TBL] [Abstract][Full Text] [Related]
35. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment. Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181 [TBL] [Abstract][Full Text] [Related]
36. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360 [TBL] [Abstract][Full Text] [Related]
38. Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Yu L; Wang CY; Shi J; Miao L; Du X; Mayer D; Zhang J Endocrinology; 2011 Mar; 152(3):773-81. PubMed ID: 21248144 [TBL] [Abstract][Full Text] [Related]
39. miR-338 inhibits the metastasis of lung cancer by targeting integrin β3. Chen X; Wei L; Zhao S Oncol Rep; 2016 Sep; 36(3):1467-74. PubMed ID: 27431198 [TBL] [Abstract][Full Text] [Related]
40. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related. Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]